These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19000504)

  • 1. [Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?].
    Homs S; González-Costello J
    Rev Esp Cardiol; 2008 Nov; 61(11):1225; author reply 1225-6. PubMed ID: 19000504
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to treat acute decompensated heart failure in the 'beta-blocker era'?
    Marcondes-Braga FG; Mangini S; Ayub-Ferreira SM; Bocchi EA; Bacal F
    Eur J Heart Fail; 2010 Aug; 12(8):893-4. PubMed ID: 20675672
    [No Abstract]   [Full Text] [Related]  

  • 4. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
    Omerovic E; Waagstein F; Swedberg K
    Eur J Heart Fail; 2010 Apr; 12(4):313-4. PubMed ID: 20335348
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
    Wikström BG
    Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G
    Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
    Levin RL; Degrange MA; Porcile R; Salvagio F; Blanco N; Botbol AL; Tanus E; del Mazo CD
    Rev Esp Cardiol; 2008 May; 61(5):471-9. PubMed ID: 18462650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
    Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J; Bouzada M; Fernández AL; Caruezo V; Taboada M; Rodríguez J; Ginesta V; Rubio J; García-Bengoechea JB; González-Juanatey JR
    Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
    Pagel PS
    Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
    [No Abstract]   [Full Text] [Related]  

  • 13. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS
    Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with PDE III inhibitor for heart failure].
    Watanabe H; Kajimoto K; Kawana M
    Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
    Ramaswamykanive H; Bihari D; Solano TR
    Anaesth Intensive Care; 2007 Jun; 35(3):409-13. PubMed ID: 17591138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
    J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
    Oliveira MT; Follador W; Martins ML; Canaviera R; Tsuji RL; Scipioni A; Barretto AC
    Arq Bras Cardiol; 2005 Jul; 85(1):9-14. PubMed ID: 16041448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The novelty in the treatment of heart failure].
    Reingardiene D
    Medicina (Kaunas); 2005; 41(7):625-31. PubMed ID: 16062032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.